A Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)
Clinical trial NCT05835011 · TERMINATED
Trial details
- NCT number
- NCT05835011
- Sponsor
- Astex Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-27
- Primary completion
- 2023-08-21
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.